Nexplanon recommended after second submission

CADTH

22 October 2020 - The first submission was withdrawn.

The CADTH Canadian Drug Expert Committee had recommended that etonogestrel extended-release radiopaque subdermal implant should be reimbursed for the prevention of pregnancy for up to three years only if one condition is met.

Yet again, the condition relates to price.

Read CADTH final recommendation for etonogestrel

Michael Wonder

Posted by:

Michael Wonder